Stock Events

Stock Events

Greenwich LifeSciences 

$16.67
32
+$1.36+8.88% Friday 20:00
-$0.25-1.52%Friday 23:56After hours

Statistics

Day High
16.58
Day Low
16.58
52W High
34.1
52W Low
7.78
Volume
216
Avg. Volume
-
Mkt Cap
244.69M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

16NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q2 2026
Next
-0.36
-0.31
-0.26
-0.21
Expected EPS
-0.335
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-19.36MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow GLSI. It's not an investment recommendation.
Amazon
7
AMZN
Apple
6
AAPL
Tesla
6
TSLA
NVIDIA
6
NVDA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Puma Biotechnology
PBYI
Mkt Cap455.81M
Puma Biotechnology focuses on the development and commercialization of drugs for the treatment of various forms of cancer, directly competing with GLSI's cancer treatment research.
Gilead Sciences
GILD
Mkt Cap171.56B
Gilead Sciences is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet medical need, including oncology.
Merck
MRK
Mkt Cap335.14B
Merck & Co. is a global healthcare company that offers cancer treatments, directly competing with GLSI's focus on breast cancer therapies.
Bristol-Myers Squibb
BMY
Mkt Cap130.39B
Bristol-Myers Squibb is a global biopharmaceutical company whose portfolio includes cancer treatments, competing in the same therapeutic areas as GLSI.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG engages in the pharmaceuticals and diagnostics business worldwide, including cancer treatment solutions that compete with GLSI's offerings.
Astrazeneca
AZN
Mkt Cap242.64B
AstraZeneca is a global, science-led biopharmaceutical business that focuses on the discovery, development, and commercialization of prescription medicines, including for cancer, competing with GLSI.
AMGEN
AMGN
Mkt Cap224.63B
Amgen is a biotechnology company that develops and produces human therapeutics, with a focus on oncology treatments that compete with GLSI's products.
Novartis
NVS
Mkt Cap286.78B
Novartis AG focuses on the development and marketing of healthcare products to prevent and treat diseases, including cancer, directly competing with GLSI's research and products.
Regeneron Pharmaceuticals
REGN
Mkt Cap82.72B
Regeneron Pharmaceuticals is a biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions, including cancer therapies that compete with GLSI.

About

Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9-amino-acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including breast cancers at low (1+), intermediate (2+), and high (3+ or overexpressing) levels.
Show more...
CEO
Snehal S. Patel
Employees
13
Country
United States
ISIN
US3968791083

Listings

XNAS
US
GLSI
BOATS
BOATS
GLSI.BOATS

0 Comments

Share your thoughts

FAQ

What is Greenwich LifeSciences stock price today?▼
The current price of GLSI is $16.67 USD — it has increased by +8.88% in the past 24 hours. Watch Greenwich LifeSciences stock price performance more closely on the chart.
What is Greenwich LifeSciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Greenwich LifeSciences stocks are traded under the ticker GLSI.
Is Greenwich LifeSciences stock price growing?▼
GLSI stock has fallen by -0.77% compared to the previous week, the month change is a +26.38% rise, over the last year Greenwich LifeSciences has showed a +36.86% increase.
What is Greenwich LifeSciences market cap?▼
Today Greenwich LifeSciences has the market capitalization of 244.69M
When is the next Greenwich LifeSciences earnings date?▼
Greenwich LifeSciences is going to release the next earnings report on November 16, 2026.
What is Greenwich LifeSciences revenue for the last year?▼
Greenwich LifeSciences revenue for the last year amounts to 0 USD.
What is Greenwich LifeSciences net income for the last year?▼
GLSI net income for the last year is -19.36M USD.
How many employees does Greenwich LifeSciences have?▼
As of August 23, 2026, the company has 13 employees.
In which sector is Greenwich LifeSciences located?▼
Greenwich LifeSciences operates in the Health & Wellness sector.
When did Greenwich LifeSciences complete a stock split?▼
The last stock split for Greenwich LifeSciences was on October 16, 2014 with a ratio of 2:1.
Where is Greenwich LifeSciences headquartered?▼
Greenwich LifeSciences is headquartered in STAFFORD, United States.